CTXR
Price
$1.33
Change
+$0.02 (+1.53%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
22.63M
VERA
Price
$21.56
Change
+$0.29 (+1.36%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
1.37B
81 days until earnings call
Interact to see
Advertisement

CTXR vs VERA

Header iconCTXR vs VERA Comparison
Open Charts CTXR vs VERABanner chart's image
Citius Pharmaceuticals
Price$1.33
Change+$0.02 (+1.53%)
Volume$455
Capitalization22.63M
Vera Therapeutics
Price$21.56
Change+$0.29 (+1.36%)
Volume$9.67K
Capitalization1.37B
CTXR vs VERA Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. VERA commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CTXR: $1.33 vs. VERA: $21.54)
Brand notoriety: CTXR and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 14% vs. VERA: 155%
Market capitalization -- CTXR: $22.63M vs. VERA: $1.37B
CTXR [@Biotechnology] is valued at $22.63M. VERA’s [@Biotechnology] market capitalization is $1.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 1 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CTXR and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 2 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • CTXR’s TA Score: 2 bullish, 6 bearish.
  • VERA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VERA is a better buy in the short-term than CTXR.

Price Growth

CTXR (@Biotechnology) experienced а +8.13% price change this week, while VERA (@Biotechnology) price change was +8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

VERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.38B) has a higher market cap than CTXR($22.6M). VERA YTD gains are higher at: -49.066 vs. CTXR (-66.750). CTXR has higher annual earnings (EBITDA): -42.77M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. CTXR (26.4K). CTXR has less debt than VERA: CTXR (932K) vs VERA (54.5M). CTXR (0) and VERA (0) have equivalent revenues.
CTXRVERACTXR / VERA
Capitalization22.6M1.38B2%
EBITDA-42.77M-167.77M25%
Gain YTD-66.750-49.066136%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.4K590M0%
Total Debt932K54.5M2%
FUNDAMENTALS RATINGS
CTXR: Fundamental Ratings
CTXR
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTXRVERA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELDN2.630.03
+1.15%
Eledon Pharmaceuticals
APLS27.750.13
+0.47%
Apellis Pharmaceuticals
DTE138.92-1.01
-0.72%
DTE Energy Company
HAFC23.60-0.56
-2.32%
Hanmi Financial Corp
CYCC7.95-0.94
-10.57%
Cyclacel Pharmaceuticals Inc

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with KLTO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then KLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
+1.53%
KLTO - CTXR
35%
Loosely correlated
+10.41%
HYPD - CTXR
32%
Poorly correlated
+7.62%
ALEC - CTXR
31%
Poorly correlated
-8.54%
VERA - CTXR
28%
Poorly correlated
+1.27%
TAOX - CTXR
28%
Poorly correlated
-8.65%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+1.27%
KYMR - VERA
59%
Loosely correlated
+2.60%
LYRA - VERA
54%
Loosely correlated
-0.70%
VYGR - VERA
38%
Loosely correlated
+0.27%
CRNX - VERA
38%
Loosely correlated
+3.47%
TBPH - VERA
38%
Loosely correlated
+1.62%
More